(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 95%, (99% ee)95%, (99% ee) | 15-8629 | Ligands | Catalysts | Other Reagents | Ver → |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee) | 15-8625 | Ligands | Catalysts | Other Reagents | Ver → |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98% | 15-8634 | Ligands | Catalysts | Other Reagents | Ver → |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee) | 15-8638 | Ligands | Catalysts | Other Reagents | Ver → |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 95%, (99% ee) | 15-8630 | Ligands | Catalysts | Other Reagents | Ver → |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98% | 15-8626 | Ligands | Catalysts | Other Reagents | Ver → |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98% | 15-8635 | Ligands | Catalysts | Other Reagents | Ver → |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-di-p-tolyltetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 98%, (99% ee) | 15-8639 | Ligands | Catalysts | Other Reagents | Ver → |
3-Bromobenzotrifluoride, min. 98% | 09-0026 | New Products | Other Reagents | Ver → |
3-Butyl-1-methylimidazolium bromide, 98% [BMIM]Br | 07-0710 | Other Reagents | Ver → |
3-Chloro-4-fluorobenzotrifluoride, 98% | 09-1863 | Other Reagents | Ver → |
3-Chlorobenzotrifluoride, min. 98% | 09-0033 | New Products | Other Reagents | Ver → |
3-Mercaptopropyl ethyl sulfide Silica (60⁺, high-cross linking) (PhosphonicS SPM36) | 16-1700 | Other Reagents | Ver → |
3-Mercaptopropyl ethyl sulfide Silica (60⁺, low-cross linking) (PhosphonicS SPM32) | 16-1706 | Other Reagents | Ver → |
3-Mercaptopropyl ethyl sulfide Silica (90⁺, low-cross linking) (PhosphonicS SPM32f) | 16-1704 | Other Reagents | Ver → |
3-Phenyl-1H-inden-1-ylidene[bis(i-butylphobane)]ruthenium(II) dichloride | 44-7778 | Catalysts | Ver → |
4,5-Dibromonaphthalene-1,8- dicarboxylic acid anhydride | 06-0132 | New Products | Other Reagents | Ver → |
4-(Azetidin-3-yloxy)-1-methyl-1H-pyrazole hydrochloride, 95% | 07-0168 | New Products | Other Reagents | Ver → |
4-Bromo-2-fluorobenzylamine hydrochloride, min. 97% | 09-0030 | New Products | Other Reagents | Ver → |
4-Carboxybutyltriphenylphosphonium bromide , min. 98% | 15-2001 | New Products | Other Reagents | Ver → |
4-Ethyl-3-fluoropyridine 1-oxide, 95% | 09-0126 | New Products | Other Reagents | Ver → |
(4R)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(tert-butyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide, 98% | 15-8530 | Ligands | Catalysts | Other Reagents | Ver → |
(4R)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide, 98%, (99% ee) | 15-0581 | Other Reagents | Ver → |
(4R)-4-i-Propyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3010 | (4R)-4-i-Propyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4R)-4-Phenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3030 | (4R)-4-Phenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4R)-4-t-Butyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3007 | (4R)-4-t-Butyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4R,5S)-3,3a,8,8a-Tetrahydroindeno[1,2-d]-1,2,3-oxathiazole-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3006 | (4R,5S)-3,3a,8,8a-Tetrahydroindeno[1,2-d]-1,2,3-oxathiazole-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4R,5S)-4,5-Diphenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3021 | (4R,5S)-4,5-Diphenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4S)-4-Hydroxy-2,6-bis(3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':3',1''-terphenyl]-5'-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-oxide, 98%, (99% ee) | 15-0563 | Other Reagents | Ver → |
(4S)-4-i-Propyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3011 | (4S)-4-i-Propyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4S)-4-Phenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3031 | (4S)-4-Phenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4S)-4-t-Butyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3008 | (4S)-4-t-Butyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4S,5R)-3,3a,8,8a-Tetrahydroindeno[1,2-d]-1,2,3-oxathiazole-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3005 | (4S,5R)-3,3a,8,8a-Tetrahydroindeno[1,2-d]-1,2,3-oxathiazole-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4S,5R)-4,5-Diphenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3020 | (4S,5R)-4,5-Diphenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
(4S,5R)-4-Methyl-5-phenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | 16-3003 | (4S,5R)-4-Methyl-5-phenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester, min. 97% | Ver → |
5-Amino-2-chlorobenzotrifluoride, min. 97% | 09-1070 | Ligands | Other Reagents | Ver → |
5-bromo-2-fluorobenzylamine hydrochloride, min. 98% | 09-0039 | New Products | Other Reagents | Ver → |
(5-Phenylpyridin-2-yl)methanamine dihydrochloride, 95% | 07-0336 | New Products | Other Reagents | Ver → |
(6aR)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) | 15-8558 | Ligands | Catalysts | Other Reagents | Ver → |
(6aS)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) | 15-8559 | Ligands | Catalysts | Other Reagents | Ver → |
(8α, 9S)-6'-Methoxycinchonan-9-amine trihydrochloride, min. 90% | 07-1710 | Catalysts | Ver → |
(8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) | 15-8554 | Ligands | Catalysts | Other Reagents | Ver → |
(8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) | 15-8555 | Ligands | Catalysts | Other Reagents | Ver → |
(9R)-10,11-Dihydro-6'-methoxycinchonan-9-amine trihydrochloride, min. 90% | 07-1722 | Catalysts | Ver → |
Allylmagnesium bromide, 0.95-1.1 M in ether | 93-1201 | Other Reagents | Ver → |
Allyltriphenylphosphonium bromide, 99% | 93-1501 | Allyltriphenylphosphonium bromide, 99% | Ver → |
Aluminum bromide, 99% | 93-1385 | Thin Film Deposition | Ver → |
Aluminum chloride, anhydrous (99.99+%-Al) PURATREM | 13-0050 | Thin Film Deposition | Ver → |
Aluminum chloride, anhydrous, reagent, 99% | 93-1387 | Thin Film Deposition | Ver → |
Aluminum chloride hexahydrate (99.9995%-Al) PURATREM | 13-1310 | Aluminum chloride hexahydrate (99.9995%-Al) PURATREM | Ver → |